Abstract

Bone resorption can negatively influence the osseointegration of dental implants. Barrier membranes for guided bone regeneration (GBR) are used to exclude nonosteogenic tissues from influencing the bone healing process. In addition to the existing barrier membranes available on the market, a growing variety of membranes for GBR with tailorable physicochemical properties are under preclinical evaluation. Hence, the aim of this review is to provide a comprehensive description of materials used for GBR and to report the main industrial and regulatory aspects allowing the commercialization of these medical devices (MDs). In particular, a summary of the main attributes defining a GBR membrane is reported along with a description of commercially available and under development membranes. Finally, strategies for the scaling-up of the manufacturing process and the regulatory framework of the main MD producers (USA, EU, Japan, China, and India) are presented. The description of the regulatory approval process of GBR membranes is representative of the typical path that medium- to high-risk MDs have to follow for an effective medical translation, which is of fundamental importance to increase the impact of biomedical research on public health.

Highlights

  • HAL is a multi-disciplinary open access archive for the deposit and dissemination of scientific research documents, whether they are published or not

  • The aim of this review is to present the latest advancement in guided bone regeneration (GBR) membranes and to describe the process leading to the industrial development of materials for such biomedical applications

  • Small pores could limit cell migration and enhance collagen deposition, reducing the ability of blood vessels to infiltrate the area of interest.[25] 4) A GBR membrane would need to be handled during surgery, without being excessively rigid, which could compromise tissue integration or lead to dehiscence of the soft tissues.[2] 5) the role of the membrane was initially intended as a passive barrier, this concept could be reconsidered in the context of the next-generation membranes

Read more

Summary

Medical Requirements for the Design of GBR Membranes

Trauma, and congenital defects can lead to tissue damage or loss, the need to replace missing form and function. Small pores could limit cell migration and enhance collagen deposition, reducing the ability of blood vessels to infiltrate the area of interest.[25] 4) A GBR membrane would need to be handled during surgery (i.e., easy handling), without being excessively rigid, which could compromise tissue integration or lead to dehiscence of the soft tissues.[2] 5) the role of the membrane was initially intended as a passive barrier, this concept could be reconsidered in the context of the next-generation membranes. A growing number of studies are developing new strategies for bone regeneration incorporating bioactive compounds into the membrane, giving it an active role in the regeneration process (i.e., bioactivation friendly property).[26,27]

Commercially Available Membranes
GBR Strategies and New Membranes under Preclinical Evaluation
Conditioned Media
Cytokines and Growth Factors
Inorganic Compounds
Antimicrobial Drugs
Extracellular-Matrix-Based Membranes
GBR Membranes with Tailored Physical Properties to Enhance Bone Regeneration
GBR Membranes in Pathological Contexts
Industrialization Process
Quality by Design
Legal Obligations of Manufacturers
Regulatory Requirements
Further control is required to ensure the safety and effectiveness
D High risk
USA Regulation
GBR Membranes
GBR Membranes from Animal Origin
General Consideration for Synthetic GBR Membranes and Manufacturing Processes
EU Regulation
Regulation in Asian Countries
Conclusion
Findings
Conflict of Interest
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call